167 related articles for article (PubMed ID: 28691327)
1. Ending cervical cancer: A call to action.
Aranda S; Berkley S; Cowal S; Dybul M; Evans T; Iversen K; Moeti M; Osotimehin B; Peterson S; Piot P; Purandare CN; Sidibé M; Trimble T; Tsu VD
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():4-6. PubMed ID: 28691327
[TBL] [Abstract][Full Text] [Related]
2. The investment case for cervical cancer elimination.
Tsu VD; Ginsburg O
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():69-73. PubMed ID: 28691328
[TBL] [Abstract][Full Text] [Related]
3. Progress in HPV vaccination in low- and lower-middle-income countries.
LaMontagne DS; Bloem PJN; Brotherton JML; Gallagher KE; Badiane O; Ndiaye C
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():7-14. PubMed ID: 28691329
[TBL] [Abstract][Full Text] [Related]
4. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
5. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
Campos NG; Sharma M; Clark A; Lee K; Geng F; Regan C; Kim J; Resch S
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():47-56. PubMed ID: 28691334
[TBL] [Abstract][Full Text] [Related]
6. Making HPV vaccination available to girls everywhere.
Oberlin AM; Rahangdale L; Chinula L; Fuseini NM; Chibwesha CJ
Int J Gynaecol Obstet; 2018 Dec; 143(3):267-276. PubMed ID: 30144050
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
8. (At Least) Once in Her Lifetime: Global Cervical Cancer Prevention.
Castle PE; Pierz A
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):107-123. PubMed ID: 30683258
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention.
Calabrò GE; Riccardi MT; D'Ambrosio F; Castagna C; Sapienza M; Millevolte R; Pellacchia A; Ricciardi R; de Vincenzo RP; de Waure C
Front Public Health; 2022; 10():1010237. PubMed ID: 36530690
[TBL] [Abstract][Full Text] [Related]
10. The next steps in cervical screening.
Sankaranarayanan R; Qiao YL; Keita N
Womens Health (Lond); 2015 Mar; 11(2):201-12. PubMed ID: 25776294
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
Jit M; Brisson M; Portnoy A; Hutubessy R
Lancet Glob Health; 2014 Jul; 2(7):e406-14. PubMed ID: 25103394
[TBL] [Abstract][Full Text] [Related]
12. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis.
Bonjour M; Charvat H; Franco EL; Piñeros M; Clifford GM; Bray F; Baussano I
Lancet Public Health; 2021 Jul; 6(7):e510-e521. PubMed ID: 33864738
[TBL] [Abstract][Full Text] [Related]
13. Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
Wittet S; Aylward J; Cowal S; Drope J; Franca E; Goltz S; Kuo T; Larson H; Luciani S; Mugisha E; Schocken C; Torode J
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():57-62. PubMed ID: 28691332
[TBL] [Abstract][Full Text] [Related]
14. Status of HPV vaccine introduction and barriers to country uptake.
Gallagher KE; LaMontagne DS; Watson-Jones D
Vaccine; 2018 Aug; 36(32 Pt A):4761-4767. PubMed ID: 29580641
[TBL] [Abstract][Full Text] [Related]
15. CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide.
Senkomago V; Duran D; Loharikar A; Hyde TB; Markowitz LE; Unger ER; Saraiya M
Emerg Infect Dis; 2017 Dec; 23(13):S101-7. PubMed ID: 29155666
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.
Kobetz E; Menard J; Hazan G; Koru-Sengul T; Joseph T; Nissan J; Barton B; Blanco J; Kornfeld J
Educ Health (Abingdon); 2011 Dec; 24(3):479. PubMed ID: 22267344
[TBL] [Abstract][Full Text] [Related]
17. Towards the global elimination of cervical cancer.
Canfell K
Papillomavirus Res; 2019 Dec; 8():100170. PubMed ID: 31176807
[TBL] [Abstract][Full Text] [Related]
18. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
[TBL] [Abstract][Full Text] [Related]
19. Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
Kumar S; Khanduri A; Sidibe A; Morgan C; Torode J; Basu P; Bhatla N; Schocken C; Bloem P
Int J Gynaecol Obstet; 2021 Jan; 152(1):32-39. PubMed ID: 33185283
[TBL] [Abstract][Full Text] [Related]
20. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
